Additionally, most studies measure AMPK activity via single time-point assessments of p-AMPK Thr172, without quantifying downstream pathway dynamics (e.g., ACC phosphorylation, ULK1 activation) or tissue-specific AMPK isoform expression—critical for understanding context-dependent regulation in NAFLD. This evidence concerns the gene PRKAA1 and metabolic dysfunction-associated steatotic liver disease.